Optimization of a GC-MS method for the profiling of microbiota-dependent metabolites in blood samples: An application to type 2 diabetes and prediabetes.
GC-MS
T2DM
gut microbiota
optimization
plasma
serum
Journal
Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
06
2022
accepted:
05
09
2022
entrez:
10
10
2022
pubmed:
11
10
2022
medline:
11
10
2022
Statut:
epublish
Résumé
Changes in serum or plasma metabolome may reflect gut microbiota dysbiosis, which is also known to occur in patients with prediabetes and type 2 diabetes (T2DM). Thus, developing a robust method for the analysis of microbiota-dependent metabolites (MDMs) is an important issue. Gas chromatography with mass spectrometry (GC-MS) is a powerful approach enabling detection of a wide range of MDMs in biofluid samples with good repeatability and reproducibility, but requires selection of a suitable solvents and conditions. For this reason, we conducted for the first time the study in which, we demonstrated an optimisation of samples preparation steps for the measurement of 75 MDMs in two matrices. Different solvents or mixtures of solvents for MDMs extraction, various concentrations and volumes of derivatizing reagents as well as temperature programs at methoxymation and silylation step, were tested. The stability, repeatability and reproducibility of the 75 MDMs measurement were assessed by determining the relative standard deviation (RSD). Finally, we used the developed method to analyse serum samples from 18 prediabetic (PreDiab group) and 24 T2DM patients (T2DM group) from our 1000PLUS cohort. The study groups were homogeneous and did not differ in age and body mass index. To select statistically significant metabolites, T2DM vs. PreDiab comparison was performed using multivariate statistics. Our experiment revealed changes in 18 MDMs belonging to different classes of compounds, and seven of them, based on the SVM classification model, were selected as a panel of potential biomarkers, able to distinguish between patients with T2DM and prediabetes.
Identifiants
pubmed: 36213115
doi: 10.3389/fmolb.2022.982672
pii: 982672
pmc: PMC9538375
doi:
Types de publication
Journal Article
Langues
eng
Pagination
982672Informations de copyright
Copyright © 2022 Mojsak, Maliszewska, Klimaszewska, Miniewska, Godzien, Sieminska, Kretowski and Ciborowski.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nutrients. 2019 Aug 28;11(9):
pubmed: 31466350
J Chromatogr A. 2013 Jan 11;1272:141-4
pubmed: 23261293
Nutrients. 2020 Dec 02;12(12):
pubmed: 33276482
Nat Rev Endocrinol. 2014 Dec;10(12):723-36
pubmed: 25287287
J Formos Med Assoc. 2019 Mar;118 Suppl 1:S10-S22
pubmed: 30269936
PLoS One. 2012;7(2):e31982
pubmed: 22384120
Cells. 2021 Nov 26;10(12):
pubmed: 34943836
Anal Chim Acta. 2020 Sep 22;1131:136-145
pubmed: 32928474
Gut Microbes. 2014 May-Jun;5(3):369-80
pubmed: 24685620
J Biosci Bioeng. 2019 Feb;127(2):160-168
pubmed: 30316697
Clin Chem. 2015 Mar;61(3):487-97
pubmed: 25524438
Metabolites. 2011 Jan 17;1(1):3-20
pubmed: 24957242
Cell Host Microbe. 2018 Jun 13;23(6):716-724
pubmed: 29902437
Int J Pediatr. 2017;2017:6424186
pubmed: 29085432
Biomolecules. 2021 Sep 28;11(10):
pubmed: 34680047
Nat Rev Immunol. 2016 May 27;16(6):341-52
pubmed: 27231050
Genes Nutr. 2018 May 16;13:13
pubmed: 29796113
Metabolomics. 2017;13(9):104
pubmed: 28804275
Int J Mol Sci. 2021 Mar 16;22(6):
pubmed: 33809459
Front Endocrinol (Lausanne). 2013 Dec 31;4:199
pubmed: 24427154
Front Mol Biosci. 2020 Dec 14;7:609806
pubmed: 33381523
Cell Mol Life Sci. 2018 Nov;75(21):3977-3990
pubmed: 30101405
BMC Endocr Disord. 2020 Nov 23;20(1):174
pubmed: 33228610
Diabetologia. 2016 Nov;59(11):2349-2359
pubmed: 27514531
J Clin Med. 2018 Dec 04;7(12):
pubmed: 30518023
Mol Neurobiol. 2013 Oct;48(2):294-301
pubmed: 23813101
Metabolites. 2021 Dec 18;11(12):
pubmed: 34940646
Clin Chem Lab Med. 2020 Apr 28;58(5):719-732
pubmed: 31639103
Clin Nutr. 2020 Oct;39(10):3189-3198
pubmed: 32164980
Diabetes. 2013 May;62(5):1730-7
pubmed: 23160532
Front Pharmacol. 2021 Nov 19;12:770240
pubmed: 34867398
Curr Protoc Mol Biol. 2016 Apr 01;114:30.4.1-30.4.32
pubmed: 27038389
Nutrients. 2016 Jan 20;8(1):
pubmed: 26805875
Sci Rep. 2017 Aug 25;7(1):9523
pubmed: 28842640
Front Physiol. 2019 Apr 16;10:428
pubmed: 31057420
Endocr Rev. 2019 Aug 1;40(4):1092-1107
pubmed: 30901029
Methods Mol Biol. 2018;1738:133-147
pubmed: 29654587
Rapid Commun Mass Spectrom. 2008 Oct;22(19):2984-92
pubmed: 18763274
Crit Rev Clin Lab Sci. 2018 Jan;55(1):21-32
pubmed: 29239245
Metabolites. 2016 Dec 29;7(1):
pubmed: 28036063
FASEB J. 2017 Apr;31(4):1449-1460
pubmed: 28007782
Ann Transl Med. 2017 Jan;5(2):36
pubmed: 28217701
Circulation. 2012 May 8;125(18):2222-31
pubmed: 22496159
Diabetes Care. 2016 Jun;39(6):988-95
pubmed: 27208342
Nat Commun. 2019 Oct 3;10(1):4505
pubmed: 31582752
PLoS One. 2010 May 28;5(5):e10883
pubmed: 20526369
Curr Issues Mol Biol. 2021 Jun 29;43(2):513-528
pubmed: 34209638
Diabetes. 2013 Dec;62(12):4270-6
pubmed: 23884885
Nature. 2021 Jul;595(7867):415-420
pubmed: 34262212
PLoS Biol. 2021 Jan 22;19(1):e3001070
pubmed: 33481771
Metabolomics. 2011 Sep;7(3):307-328
pubmed: 21949491
Anal Chim Acta. 2013 Dec 4;804:180-9
pubmed: 24267080
Nutrients. 2019 Apr 12;11(4):
pubmed: 31013777
Front Microbiol. 2016 Jul 26;7:1144
pubmed: 27507964
Can J Infect Dis Med Microbiol. 2021 Jan 8;2021:6658674
pubmed: 33505541
Front Cell Infect Microbiol. 2018 Feb 06;8:13
pubmed: 29468141
EBioMedicine. 2018 Nov;37:392-400
pubmed: 30366816
J Nutr. 2019 Jun 1;149(6):915-922
pubmed: 31049566
PLoS One. 2011;6(7):e21230
pubmed: 21760889
Diabetes Obes Metab. 2018 Nov;20(11):2661-2669
pubmed: 29943387
Sci Rep. 2021 Feb 26;11(1):4809
pubmed: 33637880
Amino Acids. 2017 Dec;49(12):2083-2090
pubmed: 28932911
Anal Biochem. 2021 May 15;621:114153
pubmed: 33684344
Metabolites. 2021 Dec 03;11(12):
pubmed: 34940595
Metabolites. 2021 Dec 24;12(1):
pubmed: 35050137
Nutr Metab (Lond). 2018 May 3;15:33
pubmed: 29755574
Metabolomics. 2018 Nov 17;14(11):152
pubmed: 30830421
Sci Rep. 2016 Dec 21;6:38885
pubmed: 28000704
Anal Chim Acta. 2014 May 8;824:42-56
pubmed: 24759747
Front Cell Infect Microbiol. 2022 Feb 15;12:834485
pubmed: 35242721
Front Immunol. 2017 Dec 20;8:1882
pubmed: 29326727
Anal Chem. 2005 Dec 15;77(24):8086-94
pubmed: 16351159
J Diabetes Investig. 2019 Sep;10(5):1209-1214
pubmed: 30756513
Curr Opin Lipidol. 2006 Feb;17(1):22-7
pubmed: 16407712
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2473-2481
pubmed: 28482070
Nature. 2016 Jul 21;535(7612):376-81
pubmed: 27409811
Front Mol Biosci. 2021 Jul 08;8:682134
pubmed: 34307452
Biopreserv Biobank. 2016 Oct;14(5):416-423
pubmed: 27348730
Sci Rep. 2020 Oct 19;10(1):17616
pubmed: 33077739
Chin Med J (Engl). 2018 Dec 05;131(23):2792-2799
pubmed: 30511681
J Proteome Res. 2017 Jul 7;16(7):2547-2559
pubmed: 28517934
Bioanalysis. 2017 Jan;9(1):53-65
pubmed: 27921459
Diabetes Metab Syndr Obes. 2017 Aug 14;10:345-361
pubmed: 28860833
Genome Biol. 2017 Apr 13;18(1):70
pubmed: 28407784
Adv Nutr. 2020 May 1;11(3):709-723
pubmed: 31825083
J Pharm Biomed Anal. 2020 Nov 30;191:113617
pubmed: 32971497
PLoS One. 2010 Feb 05;5(2):e9085
pubmed: 20140211
RSC Adv. 2020 Jan 17;10(6):3092-3104
pubmed: 35497733
Metabolomics. 2018 Feb 13;14(3):32
pubmed: 30830335
Front Med (Lausanne). 2021 Nov 29;8:765873
pubmed: 34912824
Curr Neurol Neurosci Rep. 2018 Sep 24;18(11):81
pubmed: 30251184
Diabetes. 2019 Jun;68(6):1353-1358
pubmed: 30885989
Electrophoresis. 2015 Dec;36(24):3050-60
pubmed: 26376450